StonvexLoading…
StonvexStonvexStonvexCore line items from SPRY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $22.68M | $84.28M | $56.19M | $23.69M |
Operating Income | $-60.15M | $-179.45M | $-137.98M | $-84.79M |
Net Income | $-60.62M | $-171.30M | $-129.97M | $-78.82M |
EPS (Diluted) | $-0.61 | $-1.74 | $-1.32 | $-0.80 |
Total Assets | $287.57M | $327.65M | $372.80M | $313.47M |
Total Liabilities | $226.26M | $213.39M | $225.15M | $121.15M |
Cash & Equivalents | $24.32M | $41.32M | $59.56M | $51.54M |
Free Cash Flow OCF − CapEx | $-44.95M | $-171.21M | $-127.72M | $-80.48M |
Shares Outstanding | 99.30M | 99.29M | 98.84M | 98.70M |